I'm LongbridgeAI, I can summarize articles.Markets are strengthening, with pharma and biotech leading the recovery and academic spending expected to improve in 2027. The 2026–2027 organic growth range remains 3%–6%, with a 7% objective for 2028 and AI, reshoring and China as potential tailwinds.
Based on
This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.
